Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.

× No keyword cloud information.

25 in total

Review 1. What is the cost of blindness?

Authors: C Meads; C Hyde
Journal: Br J Ophthalmol Date: 2003-10 Impact factor: 4.638

Review 2. Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.

Authors: Jordana K Schmier; Carolyn K Hulme-Lowe
Journal: Pharmacoeconomics Date: 2016-03 Impact factor: 4.981

Review 3. Economic cost of age-related macular degeneration: a review of recent research.

Authors: Kathleen M Ke; Usha Chakravarthy; Ciaran O'Neill
Journal: Drugs Aging Date: 2006 Impact factor: 3.923

4. How much is the cost of visual impairment: caveat emptor.

Authors: Catherine Meads; Chris Hyde
Journal: Pharmacoeconomics Date: 2006 Impact factor: 4.981

5. The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.

Authors: Gary C Brown; Melissa M Brown; Heidi C Brown; Sylvia Kindermann; Sanjay Sharma
Journal: Trans Am Ophthalmol Soc Date: 2007

6. Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.

Authors: Joshua D Stein; Paula Anne Newman-Casey; Tavag Mrinalini; Paul P Lee; David W Hutton
Journal: Ophthalmology Date: 2014-01-07 Impact factor: 12.079

7. Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.

Authors: L Arias; O Pujol; J Berniell; M Rubio; G Roca; L Castillo; E Acebes
Journal: Br J Ophthalmol Date: 2005-03 Impact factor: 4.638

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.